All Posts
Short Review: Ketamine for the treatment of acute pain.
2 Nov, 2021 | 02:43h | UTCKetamine for the treatment of acute pain – Canadian Medical Association Journal
Commentary on Twitter
If you manage pain in hospital, low-dose ketamine should be in your toolkit. And not just in the ED.
Quick overview with @WKSilverstein & @JonZipursky in @CMAJ: https://t.co/w5h3vIMiEK pic.twitter.com/gVO7W9dcYY
— David Juurlink (@DavidJuurlink) November 1, 2021
Observational study suggests a third dose of the Pfizer COVID-19 vaccine can prevent severe COVID-19-related outcomes, compared with only two doses received at least 5 months before.
31 Oct, 2021 | 20:14h | UTCInvited Commentary: Boosters appear effective, but are they always needed? – The Lancet
Commentaries on Twitter
Nice analysis of boosters in @TheLancet Fri.: https://t.co/KqXInFa3a9
But I want to highlight one number:
Risk of severe disease w no booster & no coexisting conditions = 1 in 32,000 (3 per 100k).
If you have no other medical problems, this is not an urgent priority. pic.twitter.com/Qwcwsf6LIY
— David Dowdy (@davidwdowdy) October 31, 2021
Study in Israel suggests third dose of BNT162b2 mRNA vaccine effective in protecting individuals against severe COVID-19-related outcomes, compared with receiving only two doses at least 5 months before. https://t.co/g3vFqVFZLI pic.twitter.com/HfbBAPY8qP
— The Lancet (@TheLancet) October 31, 2021
Adding to the body of data for booster shot effectiveness, a new @TheLancet report of over 728,000 people w/ 3 shots vs >728,000 matched controls (2 shots):
93% reduction of Covid hospitalizationshttps://t.co/cVpANpnkHs pic.twitter.com/LlBwWi2Vtw— Eric Topol (@EricTopol) October 30, 2021
Study shows fully vaccinated individuals can still catch SARS-CoV-2 delta variant and efficiently transmit infection in household settings, including to fully vaccinated contacts.
31 Oct, 2021 | 20:16h | UTCCommentaries:
COVID vaccines protect against Delta but don’t fully stop disease spread – CIDRAP
Covid: Double vaccinated can still spread virus at home – BBC
Commentary on Twitter
NEW—#COVID19 vaccines lower the risk of infection with the #DeltaVariant. However, infection can still be passed on in household settings after two doses.
Authors urge unvaccinated to get vaccinated & those eligible to receive a booster. 1/2 https://t.co/jq8DCK69Ww pic.twitter.com/1XzHnKCF01
— The Lancet (@TheLancet) October 28, 2021
Editorial: Safety and efficacy of antivirals against SARS-CoV-2 – “we need evidence not optimism”.
31 Oct, 2021 | 20:11h | UTCSafety and efficacy of antivirals against SARS-CoV-2 – The BMJ
Commentary on Twitter
"Effective antivirals have an obvious appeal, but this must not cloud objective and transparent decision making." @dpsg108 and colleagues on the government's stockpiling of molnupiravir and PF-07321332+ritonavir for covid-19https://t.co/JUj1Y9op3P
— The BMJ (@bmj_latest) October 28, 2021
CDC Study: COVID-19 vaccine associated with 5 times the protection of ‘natural immunity’.
31 Oct, 2021 | 20:09h | UTCCommentaries:
COVID-19 vaccine gives 5 times the protection of ‘natural immunity,’ data show – CIDRAP
COVID shots more protective than past infection, study shows – Associated Press
Commentary on Twitter
⚠️BREAKING—REINFECTION & NATURAL IMMUNITY—new CDC study in hospitalized adults finds: unvaccinated people with prior #COVID19 infection recently were **5 times more likely** to be reinfected / get breakthrough versus people recently fully vaccinated! 🧵 https://t.co/VGmWPmm5lE pic.twitter.com/mlt5fJ3643
— Eric Feigl-Ding (@DrEricDing) October 29, 2021
Cohort Study: Among patients with ST-segment elevation myocardial infarction, a concomitant Covid-19 diagnosis is associated with increased in-hospital mortality.
31 Oct, 2021 | 20:10h | UTCEditorial: Myocardial Infarction During the COVID-19 Pandemic – JAMA
Commentary: STEMI and COVID-19 Often a Lethal Combo, Affirms Largest Study Yet – TCTMD
Commentary from the author on Twitter (thread – click for more)
1/8 It was not unexpected that pts w/ #STEMI would fare worse w/ than w/o #COVID19 https://t.co/B7oWnJunEa
— herbaronowMD (@herbaronowMD) October 29, 2021
Opinion | Is Moderna really better than Pfizer—or is it just a higher dose?
31 Oct, 2021 | 20:06h | UTCIs Moderna Really Better Than Pfizer—Or Is It Just a Higher Dose? – The Atlantic
Commentary on Twitter
Nice piece @theatlantic explores question of: Does Moderna give better protection than Pfizer, which gives better protection than J&J (the data would say yes to both)? And – if so – is it simply a matter of the relative doses? https://t.co/Bqav2pNNi7
— Bob Wachter (@Bob_Wachter) October 30, 2021
NICE Guideline | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management.
31 Oct, 2021 | 20:03h | UTCCommentaries:
Chronic fatigue syndrome advice scraps exercise therapy – BBC
ME exercise therapy guidance scrapped by health watchdog Nice – The Guardian
RCT: Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery.
31 Oct, 2021 | 20:00h | UTC
Cardiovascular clinical examination: the need for an evidence-based approach.
31 Oct, 2021 | 19:57h | UTC
Commentary on Twitter
Which role for cardiac clinical examination today?
According to new cardiopulse, cardiac physical diagnosis shold be regarded as a science that can be learnt, rather than an art that can only be aspired to.https://t.co/oG1NJusXrS#cardiotwitter, @ESC_Journals, @escardio. pic.twitter.com/B9iUSv0gnj— EHJ Editor-in-Chief (@ehj_ed) October 30, 2021
Study suggests smoking cessation, but not reduction, is associated with reduced risk of cardiovascular disease.
31 Oct, 2021 | 19:59h | UTCSmoking cessation, but not reduction, reduces cardiovascular disease incidence – European Heart Journal (link to abstract – $ for full-text)
Commentary on Twitter
May I just reduce the number of cigarettes? New study shows this is not enough! Smoking cessation, but not reduction, was associated with cardiovascular disease incidence drop.https://t.co/lVgXMwavNs#smoke, #cigarettes, #MI, #cardiotwitter, @ESC_Journals, @escardio. pic.twitter.com/FrqB5V2tx3
— EHJ Editor-in-Chief (@ehj_ed) October 31, 2021
Review: Clinical management of pancreatic premalignant lesions.
31 Oct, 2021 | 19:56h | UTCClinical Management of Pancreatic Premalignant Lesions – Gastroenterology
Imaging of congenital lung diseases presenting in the adulthood: a pictorial review.
31 Oct, 2021 | 19:53h | UTC
Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.
29 Oct, 2021 | 10:20h | UTCRelated:
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Review: How I manage a patient with MRSA bacteremia.
31 Oct, 2021 | 19:54h | UTCHow I manage a patient with MRSA bacteraemia – Clinical Microbiology and Infection
The effectiveness of the AstraZeneca vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo was 77.9% against symptomatic Covid-19, 87.6% against hospitalization, and 93.6% against death.
29 Oct, 2021 | 10:25h | UTC
Commentary on Twitter (thread – click for more)
https://twitter.com/MHitchingsEpi/status/1453779176826105857
Under-reporting of deaths limits our understanding of true burden of covid-19.
29 Oct, 2021 | 10:18h | UTCUnder-reporting of deaths limits our understanding of true burden of covid-19 – The BMJ
Related:
Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.
Just how do deaths due to COVID-19 stack up?
Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
Commentary on Twitter
Mortality data have been essential in understanding the spread of covid-19 and navigating the trade-offs that underlie political decision making, yet under-reporting in official death records has greatly obscured this understanding.
What should be done?https://t.co/pI8aVpa3NR
— The BMJ (@bmj_latest) October 14, 2021
Complications of critical COVID-19: Diagnostic and therapeutic considerations for the mechanically ventilated patient.
29 Oct, 2021 | 10:14h | UTC
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
29 Oct, 2021 | 10:16h | UTCmRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern – Science
Commentary from the author on Twitter (thread – click for more)
Antibodies come and go, but memory cells are forever (maybe not forever, but at least 6 months). Our latest in @ScienceMagazine: https://t.co/YHHBMrMsTA
How long does immune memory last after #mRNA vax? Is it effective vs. variants? What about “boosted” responses?
Full 🧵⬇️… pic.twitter.com/oZ5BxLuVdw
— Rishi Goel (@rishirajgoel) October 14, 2021
2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain.
29 Oct, 2021 | 09:57h | UTCExecutive Summary: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain – Journal of the American College of Cardiology
News Release: First-Ever Guideline Focused Solely on Chest Pain Evaluation, Diagnosis Released
Guideline Hub: Guideline for the Evaluation and Diagnosis of Chest Pain
Key Points: 2021 AHA/ACC Chest Pain Guideline – American College of Cardiology
Commentary: New Chest Pain Guidelines Out at Last: Most Tests Have a Role – TCTMD
Commentary on Twitter (thread – click for more)
The Chest Pain Guidelines are now released!https://t.co/xQxCWzReEN
Top 10: CHEST PAINS
Thanks to the entire writing group and my co-cahirs: Deb Murkerjee & Phil Levy
💥First Chest Pain Guidelines @AHAScience @ACCinTouch pic.twitter.com/s17piamrKR— Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 (@DrMarthaGulati) October 28, 2021
Nine Pandemic Words That Almost No One Gets Right.
29 Oct, 2021 | 10:12h | UTCNine Pandemic Words That Almost No One Gets Right – The Atlantic
Systematic Review: Not enough evidence to inform the decision to either interrupt or continue anticoagulation before catheter ablation in patients with arrhythmia.
29 Oct, 2021 | 09:50h | UTC
Systematic Review: GLP-1 receptor agonists and SGLT-2 inhibitors are likely to reduce the risk of death from cardiovascular disease and death from any cause in people with both diabetes and established cardiovascular disease.
29 Oct, 2021 | 09:52h | UTC
Commentary on Twitter
The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease https://t.co/0FwffSCqbC New @CochraneHeart network meta-analysis looks at evidence from 31 studies. #CardiovascularResearch
— The Cochrane Library (@CochraneLibrary) October 27, 2021
WHO Guideline for clinical management of exposure to lead.
29 Oct, 2021 | 09:56h | UTCGuideline for clinical management of exposure to lead – World Health Organization
Executive Summary: Guideline for clinical management of exposure to lead
See also: International Lead Poisoning Prevention Week 2021
Commentary on Twitter (thread – click for more)
It's International Lead Poisoning Prevention Week
Exposure to lead affects human health, especially children's health. There is no safe level of exposure to lead. Even low levels of lead exposure may cause lifelong health problems.
Let's #BanLeadPaint
👉https://t.co/O7NeRcMrW7 pic.twitter.com/mBV13Urf9r
— World Health Organization (WHO) (@WHO) October 24, 2021
Systematic Review: Management of cutaneous immune-related adverse events in patients with cancer treated with immune checkpoint inhibitors.
29 Oct, 2021 | 09:46h | UTCManagement of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic Review – JAMA Oncology (free for a limited period)


